ArticleJournal of medical case reports2026
Acute intermittent porphyria presenting as posterior reversible encephalopathy syndrome: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute intermittent porphyria (AIP) is a rare metabolic disorder of heme biosynthesis. It usually presents with abdominal pain, gastrointestinal disturbances, and neuropsychiatric manifestations. Posterior reversible encephalopathy syndrome (PRES), characterized by seizures, altered mental status, and characteristic imaging findings, is an unusual and under-recognized presentation of AIP. CASE PRESENTATION: We present the case of a 16-year-old South Asian male with a 2-month history of recurrent abdominal pain, nausea, vomiting, and constipation, who developed sudden-onset generalized tonic-clonic seizures. Initial workup revealed hyponatremia and elevated liver enzymes. MRI of the brain showed findings consistent with PRES. Further history and investigations, including elevated urinary porphobilinogen levels, confirmed the diagnosis of AIP. The patient was managed conservatively with carbohydrate loading, avoidance of precipitating factors, and antiepileptic therapy, leading to gradual clinical improvement. A repeat MRI showed partial resolution of lesions, confirming the reversibility of PRES.
conclusionThis case highlights the importance of considering AIP in young patients presenting with gastrointestinal and neurological symptoms. PRES as a manifestation of AIP is rare but should be recognized promptly, as early diagnosis and conservative management can lead to a favorable outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.